湖北共同藥(yao)業(ye)(ye)股(gu)份公(gong)(gong)司(si)是是一家從事甾(zai)體(ti)(ti)激(ji)素(su)(su)藥(yao)物(wu)(wu)(wu)(wu)原料(liao)的研發、生產(chan)(chan)(chan)及銷售(shou)的高新技術企(qi)業(ye)(ye),主要產(chan)(chan)(chan)品為甾(zai)體(ti)(ti)藥(yao)物(wu)(wu)(wu)(wu)生產(chan)(chan)(chan)所需的起(qi)(qi)始(shi)物(wu)(wu)(wu)(wu)料(liao)和中間體(ti)(ti)。在甾(zai)體(ti)(ti)藥(yao)物(wu)(wu)(wu)(wu)起(qi)(qi)始(shi)物(wu)(wu)(wu)(wu)料(liao)領域,公(gong)(gong)司(si)是國內(nei)較大的供應商之一;在甾(zai)體(ti)(ti)藥(yao)物(wu)(wu)(wu)(wu)中間體(ti)(ti)領域,公(gong)(gong)司(si)掌握(wo)了多(duo)種(zhong)產(chan)(chan)(chan)品的生產(chan)(chan)(chan)技術,實現了起(qi)(qi)始(shi)物(wu)(wu)(wu)(wu)料(liao)至性激(ji)素(su)(su)類中間體(ti)(ti)的完整產(chan)(chan)(chan)品路線(xian)覆蓋,并(bing)能(neng)夠(gou)生產(chan)(chan)(chan)多(duo)種(zhong)皮質(zhi)激(ji)素(su)(su)類中間體(ti)(ti)和孕激(ji)素(su)(su)類中間體(ti)(ti),產(chan)(chan)(chan)品線(xian)豐(feng)富,能(neng)夠(gou)滿足客(ke)戶的多(duo)元化需求并(bing)受到市(shi)場認可。公(gong)(gong)司(si)已與國內(nei)甾(zai)體(ti)(ti)藥(yao)物(wu)(wu)(wu)(wu)龍頭企(qi)業(ye)(ye)天藥(yao)股(gu)份、溢多(duo)利、以及國際(ji)制藥(yao)企(qi)業(ye)(ye) CHEMO 和 AMRI 等國內(nei)外客(ke)戶建立了良好的合(he)作關系。